JP2017521490A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017521490A5 JP2017521490A5 JP2017519730A JP2017519730A JP2017521490A5 JP 2017521490 A5 JP2017521490 A5 JP 2017521490A5 JP 2017519730 A JP2017519730 A JP 2017519730A JP 2017519730 A JP2017519730 A JP 2017519730A JP 2017521490 A5 JP2017521490 A5 JP 2017521490A5
- Authority
- JP
- Japan
- Prior art keywords
- htra
- amino acids
- bacterial
- fragment
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101001041393 Homo sapiens Serine protease HTRA1 Proteins 0.000 claims 20
- 102100021119 Serine protease HTRA1 Human genes 0.000 claims 20
- 229920001184 polypeptide Polymers 0.000 claims 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims 15
- 150000001413 amino acids Chemical class 0.000 claims 13
- 239000012634 fragment Substances 0.000 claims 13
- 230000001580 bacterial effect Effects 0.000 claims 11
- 230000002163 immunogen Effects 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- 241000894006 Bacteria Species 0.000 claims 6
- 241000590002 Helicobacter pylori Species 0.000 claims 5
- 206010061218 Inflammation Diseases 0.000 claims 5
- 229940037467 helicobacter pylori Drugs 0.000 claims 5
- 230000004054 inflammatory process Effects 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 208000007882 Gastritis Diseases 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 206010013864 duodenitis Diseases 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 229940021747 therapeutic vaccine Drugs 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 210000001198 duodenum Anatomy 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014902493A AU2014902493A0 (en) | 2014-06-30 | Helicobacter therapeutic | |
| AU2014902493 | 2014-06-30 | ||
| PCT/AU2015/000380 WO2016000022A1 (en) | 2014-06-30 | 2015-06-30 | Helicobacter therapeutic |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017521490A JP2017521490A (ja) | 2017-08-03 |
| JP2017521490A5 true JP2017521490A5 (OSRAM) | 2018-08-09 |
| JP6634444B2 JP6634444B2 (ja) | 2020-01-22 |
Family
ID=55018143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017519730A Active JP6634444B2 (ja) | 2014-06-30 | 2015-06-30 | ヘリコバクター治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20170165347A1 (OSRAM) |
| EP (1) | EP3160492A4 (OSRAM) |
| JP (1) | JP6634444B2 (OSRAM) |
| KR (1) | KR102481455B1 (OSRAM) |
| CN (2) | CN106573038A (OSRAM) |
| AU (1) | AU2015283805B2 (OSRAM) |
| BR (1) | BR112016030728A2 (OSRAM) |
| RU (1) | RU2017100658A (OSRAM) |
| WO (1) | WO2016000022A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101885460B1 (ko) | 2017-02-07 | 2018-08-03 | 두산중공업 주식회사 | 가스터빈용 프리 스월러 장치 |
| CN108531468B (zh) * | 2018-02-24 | 2020-07-17 | 广东工业大学 | 编码重组幽门螺杆菌丝氨酸蛋白酶的基因、卵黄抗体与应用 |
| KR102500799B1 (ko) | 2018-03-09 | 2023-02-20 | 삼성디스플레이 주식회사 | 트랜지스터 기판 및 이를 구비하는 표시 장치 |
| RU2746590C1 (ru) * | 2020-10-12 | 2021-04-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Вятский государственный университет" | Способ эрадикации бактерий Helicobacter pylori при экспериментальном хеликобактериозе у конвенциональных белых мышей и средство для его осуществления |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| ATE475668T1 (de) | 1994-01-27 | 2010-08-15 | Univ Massachusetts Medical | Immunisierung durch impfung von dns transkriptionseinheit |
| US5939400A (en) | 1996-02-26 | 1999-08-17 | The Board Of Trustees Of The Leland Stanford Junior University | DNA vaccination for induction of suppressive T cell response |
| WO1997044446A1 (en) | 1996-05-24 | 1997-11-27 | University Of Maryland At Baltimore | Dna vaccines for eliciting a mucosal immune response |
| WO1998049314A2 (en) * | 1997-04-25 | 1998-11-05 | Genelabs Technologies, Inc. | ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI) |
| IT1298087B1 (it) | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
| GB9808720D0 (en) * | 1998-04-23 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| US6585975B1 (en) * | 1998-04-30 | 2003-07-01 | Acambis, Inc. | Use of Salmonella vectors for vaccination against helicobacter infection |
| AUPP684998A0 (en) * | 1998-10-30 | 1998-11-26 | Murdoch Institute for Research into Birth Defects Limited, The | A method of recombination and agents useful for same |
| US6319224B1 (en) | 1999-08-20 | 2001-11-20 | Bioject Medical Technologies Inc. | Intradermal injection system for injecting DNA-based injectables into humans |
| US6494865B1 (en) | 1999-10-14 | 2002-12-17 | Becton Dickinson And Company | Intradermal delivery device including a needle assembly |
| AU2001258373A1 (en) * | 2000-04-27 | 2001-11-12 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Method for identifying helicobacter antigens |
| US7015033B1 (en) * | 2000-05-25 | 2006-03-21 | Aventis Pasteur Limited | Co-expression of recombination proteins |
| GB0103170D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| FR2815544B1 (fr) | 2000-10-23 | 2003-02-14 | Poudres & Explosifs Ste Nale | Seringue sans aiguille securisee a architecture compacte |
| AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| JP2007524366A (ja) * | 2003-04-22 | 2007-08-30 | インターツェル・アクチェンゲゼルシャフト | ピロリ菌抗原 |
| WO2007087576A2 (en) * | 2006-01-24 | 2007-08-02 | The Uab Research Foundation | Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases |
| CN101443353A (zh) * | 2006-03-15 | 2009-05-27 | Csir公司 | 谷氨酰胺合成酶活性的调节 |
| WO2009026615A1 (en) * | 2007-08-24 | 2009-03-05 | University Of Wollongong | Group a streptococcus pharmaceutical compositions and methods thereof |
| WO2010068413A1 (en) * | 2008-11-25 | 2010-06-17 | Emergent Product Development Gaithersburg Inc. | Chlamydia vaccine comprising htra polypeptides |
-
2015
- 2015-06-30 KR KR1020177002217A patent/KR102481455B1/ko active Active
- 2015-06-30 BR BR112016030728A patent/BR112016030728A2/pt not_active Application Discontinuation
- 2015-06-30 CN CN201580035276.6A patent/CN106573038A/zh active Pending
- 2015-06-30 WO PCT/AU2015/000380 patent/WO2016000022A1/en not_active Ceased
- 2015-06-30 JP JP2017519730A patent/JP6634444B2/ja active Active
- 2015-06-30 EP EP15814180.4A patent/EP3160492A4/en not_active Ceased
- 2015-06-30 RU RU2017100658A patent/RU2017100658A/ru not_active Application Discontinuation
- 2015-06-30 CN CN202110962088.5A patent/CN113694191A/zh active Pending
- 2015-06-30 US US15/321,933 patent/US20170165347A1/en not_active Abandoned
- 2015-06-30 AU AU2015283805A patent/AU2015283805B2/en active Active
-
2019
- 2019-09-18 US US16/574,625 patent/US20200108135A1/en not_active Abandoned
-
2021
- 2021-08-27 US US17/459,715 patent/US11819546B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013534532A5 (OSRAM) | ||
| JP2007097598A5 (OSRAM) | ||
| JP2016528247A5 (OSRAM) | ||
| JP2018527919A5 (OSRAM) | ||
| JP2012522808A5 (OSRAM) | ||
| JP2011250797A5 (OSRAM) | ||
| JP2016529229A5 (OSRAM) | ||
| PE20181336A1 (es) | Anticuerpos que se unen a interleucina 8 (il-8) y sus usos | |
| NO20076239L (no) | Peptidkonjugatpreparater og fremgangsmater for forebygging og behandling av Alzheimers sykdom | |
| JP2012504955A5 (OSRAM) | ||
| JP2012525128A5 (OSRAM) | ||
| RU2011152816A (ru) | ПРИМЕНЕНИЕ АНТИТЕЛА ПРОТИВ Tau pS422 ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ГОЛОВНОГО МОЗГА | |
| MY205774A (en) | Human il-4r binding antibody, antigen binding fragment thereof, and medical use thereof | |
| JP2016539946A5 (OSRAM) | ||
| JP2015522252A5 (OSRAM) | ||
| JP2017521490A5 (OSRAM) | ||
| JP2016503413A5 (OSRAM) | ||
| JP2019509054A5 (OSRAM) | ||
| JP2017515473A5 (OSRAM) | ||
| Zhang et al. | Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon | |
| JP2018529661A5 (OSRAM) | ||
| JP2017505305A5 (OSRAM) | ||
| JP2015529677A5 (OSRAM) | ||
| RU2017100658A (ru) | ТЕРАПЕВТИЧЕСКОЕ СРЕДСТВО ПРОТИВ Helicobacter | |
| JP2016516078A5 (OSRAM) |